Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 11 (116th)

Commitment to American GROWTH Act

referredUnited States· United States Congress· EN

Introduced

9 October 2020

Last action

9 October 2020 · Introduced

Status

Referred to the House Committee on Ways and Means.

Sponsors

Rep. Brady, Kevin [R-TX-8], Rep. Arrington, Jodey C. [R-TX-19], Rep. Walorski, Jackie [R-IN-2], Rep. LaHood, Darin [R-IL-16], Rep. Ferguson, A. Drew, IV [R-GA-3], Rep. Marchant, Kenny [R-TX-24], Rep. Reed, Tom [R-NY-23], Rep. Estes, Ron [R-KS-4], Rep. Smith, Adrian [R-NE-3], Rep. Kustoff, David [R-TN-8], Rep. Flores, Bill [R-TX-17], Rep. Hern, Kevin [R-OK-1], Rep. Balderson, Troy [R-OH-12], Rep. Wenstrup, Brad R. [R-OH-2], Rep. Reschenthaler, Guy [R-PA-14], Rep. Miller, Carol D. [R-WV-1]

Subjects

Taxation

Source updated

7 April 2025

Taxation

Summary

Commitment to American Growth, Renewal, and Opportunities for Workers, Technology, and Health Act or the Commitment to American GROWTH Act This bill provides tax incentives for economic growth, research and development, and small business start-ups. Specifically, the bill makes permanent the expensing of qualified property (i.e., business property with a recovery period of 20 years or less, computer software, water utility property, and certain theatrical and film properties); allows full expensing (currently, amortization for 60 months) of certain research and experimental expenditures; increases to 40% the rate of the tax credit for increasing research activities and increases the payroll tax offset of such credit for small businesses; sets forth a rule for determining the fair market value of intangible property held by controlled foreign corporations that is transferred to U.S. shareholders; allows new tax credits for domestic medical and drug manufacturing and medical manufacturing equipment; exempts from the definition of passive activity , for purposes of the passive loss tax rules, medical research activity of a medical research small business pass-thru entity; and revises and provides for the capitalization of start-up and organizational expenditures.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 9 October 2020

    Introduced

    Referred to the House Committee on Ways and Means.

    Source: IntroReferral

  2. 9 October 2020

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 9 October 2020

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 9 October 2020

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 9 October 2020

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 9 October 2020

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.